Beneficial effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis

Journal of Clinical Biochemistry and Nutrition

Volumn 44, Issue 3, 2009, Pages 239-246

  Nakamoto, Kazuo ^a   Takayama, Fusako ^a   Mankura, Mitsumasa ^a,b   Hidaka, Yuki ^a,b   Egashira, Toru ^a   Ogino, Tetsuya ^a   Kawasaki, Hiromu ^a   Mori, Akitane ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Ikeda Food Research Co Ltd   (Japan)

Author keywords

Antioxidant; Hepatoprotection; Non alcoholic steatohepatitis; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; GREEN TEA EXTRACT; NITRITE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MEGADOSE; FATTY LIVER; FERMENTATION; HISTOCHEMISTRY; LIPID PEROXIDATION; LIVER; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; LOW DRUG DOSE; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; RATTUS;

EID: 68549125103     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.08-256     Document Type: Article

References (25)

1. Ludwig, J., Viggiano, T.R., McGill, D.B., and Oh, B.J.: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc., 55, 434-438, 1980.
2. Day, C.P. and James, O.: Steatohepatitis: a tale of "two hits"?. Gastroenterology, 114, 842-845, 1998.
3. th Annual Meeting of The Japanese Pharmacological Society, Yokohama, Japan, March 8-10, 100, p. 164, 2006.
4. Leclercq, I.A.: Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis? Clin. Sci., 106, 235-237, 2004.
5. Videla, L.A., Rodrigo, R., Orellana, M., Fernandez, V., Tapia, G., Quinones, L., Varela, N., Contreras, J., Lazarte, R., Csendes, A., Rojas, J., Maluenda, F., Burdiles, P., Diaz, J.C., Smok, G., Thielemann, L., and Poniachik, J.: Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci., 106, 261-268, 2004.
6. Higdon, J.V. and Frei, B.: Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr., 43, 89-143, 2003.
7. Zhi, Z., Froh, M., Connor, H.D., Li, X., Conzelmann, L.O., Mason, R.P., Lemasters, J.J., and Thurman, R.G.: Prevention of hepatic ischemia-reperfusion injury by green tea extract. Am. J. Physiol. Gastrointest. Liver Physiol., 283, 957-964, 2002.
8. Zhi, Z., Froh, M., Lehnert, M., Schoonhoven, R., Yang, L., Lind, H., Lemasters, J.J., and Thurman, R.G.: Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats. Am. J. Physiol. Gastrointest. Liver Physiol., 285, 1004-1013, 2003.
9. Li, Y.M., Zhang, X.G., Zhou, H.L., Chen, S.H., Zhang, Y., and Yu, C.H.: Effects of tea polyphenols on hepatic fibrosis in rats with alcoholic liver disease Hepatobiliary Pancreat. Dis. Int., 3, 577-579, 2004.
10. Arteel, G.E., Uesugi, T., Bevan, L.N., Gäbele, E., Wheeler, M.D., McKim, S.E., and Thurman, R.G.: Green tea extract protects against early alcohol-induced liver injury in rats. Biol. Chem., 383, 663-670, 2002.
11. Folch, J., Lees, M., and Sloane Stanly, G.H.: A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509, 1957.
12. Egashira, T. and Takayama, F.: Free radicals and oxidative stress: targeted ESR measurement of free radicals. Nippon Yakurigaku Zasshi, 120, 229-236, 2002.
13. Takayama, F., Egashira, T., Kudo, Y., and Yamanaka, Y.: Effects of anti-free radical interventions on phosphatidyl-choline hydroperoxide in plasma after ischemia-reperfusion in the liver of rats. Biochem. Pharmacol., 46, 1749-1757, 1993.
14. Takayama, F., Egashira, T., and Yamanaka, Y.: Effect of diclofenac, a non-steroidal anti-inflammatory drug, on lipid peroxidation caused by ischemia-reperfusion in rat liver. Jpn. J. Pharmacol., 64, 71-78, 1994.
15. Hogeboom, G.H.: Fractionation of cell components of animal tissues. Meth. Enzymol., 1, 16-19, 1955.
16. Wang, Y., Fang, J., Leonard, S.S., and Rao, K.M.: Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic. Biol. Med., 36, 1434-1443, 2004.
17. Kuzu, N., Bahcecioglu, I.H., Dagli, A.F., Ozercan, I.H., Ustündag, B., and Sahin, K.: Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. J. Gastroenterol Hepatol., 23, 465-470, 2007.
18. Bruno, R.S., Dugan, C.E., Smyth, J.A., DiNatale, D.A., and Koo, S.I.: Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J. Nutr., 1388, 323-331, 2008.
19. Sanyal, A.J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W.B., Contos, M.J., Sterling, R.K., Luketic, V.A., Shiffman, M.L., and Clore, J.N.: Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondorial abnormalities. Gastroenterology, 120, 1183-1192, 2001. (Pubitemid 32246672)
20. Robertson, G., Leclercq, I., and Farrell, G.C.: Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol., 281, 1135-1139, 2001.
21. Pessayre, D., Mansouri, A., and Fromenty, B.: Nonalcoholic steatosis and steatohepatitis V Mitochondrial dysfunction in steatohepatitis. Am. J. Physiol., 282, 193-199, 2002.
22. Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X.X., Pandey, S.K., Bhanot, S., Monia, B.P., Li, Y.X., and Diehl, A.M.: Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with no nalcoholic steatohepatitis. Hepatology, 45, 1366-1374, 2007. (Pubitemid 46918320)
23. Caldwell, S.H., Swerdlow, R.H., Khan, E.M., Iezzoni, J.C., Hespenheide, E.E., Parks, J.K., and Parker, W.D. Jr.: Mitochondrial abnormalities in non-alcoholic steatohepatitis. J. Hepatol., 31, 430-434, 1999.
24. Begriche, K., Igoudjil, A., Pessayre, D., and Fromenty, B.: Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion, 6, 1-28, 2006. (Pubitemid 43250588)
25. Wei, Y., Rector, R.S., Thyfault, J.P., and Ibdah, J.A.: Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J. Gastroenterol., 14, 193-199, 2008.